Long-acting lipoglycopeptides are as effective as standard-of-care antibiotics in treating serious bacterial infections in ...

An international research team led by the Helmholtz Center for Infection Research (HZI) has discovered a new strategy used by ...

As antibiotic-resistant "superbugs" make infections trickier to treat, some in the medical community are turning to ...

New research analyzing an online survey of 1,633 respondents found a 15% recent use of doxycycline post- and pre‐exposure ...

Vaginal microbiome-drug interactions affect antibiotic treatment for bacterial vaginosis, emphasizing the need for ...

Bacteria are ubiquitous microscopic organisms capable of rapid growth. While beneficial strains like lactic acid bacteria ...

Storied Japanese pharma Shionogi is upping its arsenal in the fight against antibiotic resistance. | Storied Japanese pharma ...

AbbVie has claimed FDA approval for Emblaveo, a new antibiotic product to treat complicated intra-abdominal infections (cIAI), including those caused by Gram-negative bacteria that represent a ...

Because COVID-19 is caused by a virus, antibiotics cannot be used to treat it. However, Pulia says physicians may feel they ...

As I head into my 25th year of working as a clinical infectious diseases pharmacist, one of the most important working relationships of my career is with the infection prevention department.

In-vitro tests have shown that pneumococci are highly susceptible to penicillin. 1–6 This has been confirmed in the treatment of experimental infections in mice 7,8 and in chick embryos. 9 ...